Stock Price Forecast

Dec. 22, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Axcella Health Inc chart...

About the Company

axcella has pioneered a new therapeutic class – defined amino acid compositions (daacs™). our daac therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease. with our axcellerator™ platform, we are transforming traditional drug discovery and development by generating patient data in less than a year from indication selection. this platform has delivered a rich pipeline including clinical programs in liver, metabolic, cns and orphan diseases.

Exchange

OTC MARKETS

Website

pronutriabio.com

$3B

Total Revenue

58

Employees

$37M

Market Capitalization

-0.84

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AXLA News

Axcella Health Inc. (AXLA) stock forecast and price target

2y ago, source: Yahoo Finance

Find the latest Axcella Health Inc. AXLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Axcella Health Inc. (AXLA)

25d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Complete Coverage

1y ago, source: CTV News

CHICAGO -- One of the first trials aimed at tackling long COVID helped some patients recover from lingering physical and mental fatigue, although the drug developed by Axcella Health Inc failed on ...

Flagship Ventures Fund 2007, L.P.'s Net Worth

6d ago, source: Benzinga.com

Who is Flagship Ventures Fund 2007, L.P.? Flagship Ventures Fund 2007, L.P. has an estimated net worth of $280 Million. This is based on reported shares across multiple companies, which include ...

Flagship Ventures 2007 General Partner LLC's Net Worth

6d ago, source: Benzinga.com

Who is Flagship Ventures 2007 General Partner LLC? Flagship Ventures 2007 General Partner LLC has an estimated net worth of $280 Million. This is based on reported shares across multiple companies ...

Axcella antes up in key liver diseases with EMM (endogenous metabolic modulator) compositions

3y ago, source: Nature

to treat complex diseases and restore health. One such disease, nonalcoholic steatohepatitis (NASH), is characterized by dysregulated metabolism, inflammation and fibrosis. According to Axcella ...

Cardinal Health Inc CAH

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Guardant Health Inc GH

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Axcella Health Inc. Common Stock (AXLA)

2y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Axcella Health Inc. Common Stock (AXLA)

4y ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...